← Home / TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA)
Stock Analysis
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA)
TEVA
TEVA · Healthcare • Pharma
34.83 -1.64%
Track TEVA in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when TEVA price is:
52W Range Position
93%
LOWMIDHIGH
Trend
Constructive
Momentum
Neutral
Updated: 2026-07-31 15:49 UTC
WOI Investment Thesis
Constructive
Confirmation improves above 36.34. Holding above 33.30 keeps the current thesis intact.
⚖️
✓
Fundamentals
Moderate / Improving
✓
Price Structure
Constructive
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
33.30
↗
Break Above
Confirmation improves above resistance.
36.34
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 33.30
Recent Company Events
SEC VERIFIED
Latest material filings
JUL
29
●
Financial Results
HIGH
TEVA reports financial results
On July 29, 2026, Teva Pharmaceutical Industries Ltd.
8-K Filing • SEC EDGAR
APR
29
●
Financial Results
HIGH
LC. These strong first quarter results were driven by our innovative portfolio growth and disciplined execution, even with lower revenues
Teva Pharmaceutical Industries Ltd.
8-K Filing • SEC EDGAR
What's Driving TEVA?
📈 Technical recovery is improving
Momentum is Neutral. Watch 36.34 for confirmation and 33.30 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 32.96 would weaken the current structure.
Full Analysis Workspace
Technical Signal
Technical Setup Active
✓
An active technical structure is present. Use trigger, target, stop and watch levels for context.
Downtrend Structure
Downtrend line not broken yet · score 10
Trigger
36.67
Invalidation
36.67
RSI(14)
60.0
◎
How to read this setup
The next meaningful technical decision is likely to occur between support at 32.96 and resistance at 36.67. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup.
Price Chart
TEVA — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-30
Fair
Fair valuation
The earnings multiple is in a moderate range.
Market Cap
$33.3B
Company size
EV
$58.4B
Debt-adjusted value
P/E
21.3
Reasonable
P/S
1.9
Low sales multiple
P/B
4.0
Balanced
EV/Sales
3.4
Low sales multiple
EV/EBIT
25.5
Reasonable
P/FCF
28.5
Reasonable
FCF Yield
3.50%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Improving business, cash flow needs monitoring
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
↗
Revenue Growth
Moderate
●
Profitability
Improving
≈
Cash Flow
Pressured
⚖
Balance Sheet
Stretched
💵 Revenue
3.98B
≈ Moderate
📈 Net Income
369.00M
↗ Improving
🧮 EPS (Basic)
0.32
↗ Improving
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Healthcare • Pharma
Related Opportunities